Did you know?
Web(cisplatin for injection, USP) is a white to light yellow lyophilized powder. Each vial of PLATINOL contains 50 mg cisplatin, 450 mg Sodium Chloride, USP, and 500 mg Mannitol, USP. The active... WebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have …
WebApr 3, 2024 · Pemetrexed Disodium Injection, Powder, Lyophilized, For Solution Intravenous - Details, Usage & Precautions. Labeler Index. Fresenius Kabi Usa, Llc. 63323-450. Label and Warnings: 63323-450 Pemetrexed. ... in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non … WebMaterial Name: Cisplatin Freeze-Dried Powder for Injection Trade Name: Platamine; Cisplatino; Platiblastin; Platistin Chemical Family: Mixture Intended Use: Pharmaceutical …
WebApr 19, 2024 · Cisplatin is a heavy metal complex containing a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. It is … Cisplatin for injection, USP, a platinum-based drug for intravenous use, is a white to light yellow lyophilized powder. Each vial of Cisplatin for injection, USP contains 50 mg Cisplatin, 450 mg Sodium Chloride, USP, and 500 mg Mannitol, USP. Cisplatin for Injection, USP may contain hydrochloric acid for pH adjustment. … See more Cisplatin for injection, USP: single-dose vials containing 50 mg of Cisplatin as white to light yellow lyophilized powder for reconstitution. See more Cisplatin for injection is contraindicated in patients with severe hypersensitivity to Cisplatin [see Warnings and Precautions (5.4)]. See more
WebMar 15, 2024 · PurposeThe purpose of this study is to evaluate the pharmacokinetics and histopathological findings of transarterial chemoembolization (TACE) using cisplatin powder mixed with degradable starch microspheres (DSM) (Cis/DSM-TACE) compared with cisplatin arterial infusion (Cis-AI).Materials and MethodsEighteen rabbits with VX2 liver …
WebCisplatin is a platinum-containing, broad activity antineoplastic and alkylating agent effective against solid tumors of testes, ovaries, and bladder; epithelial malignancies; and … inconsistent characters in romeo and julietWebJun 15, 2024 · Wang et al. indicated that miR-17 targets c-Jun activation domain binding protein 1 (JAB1) to promote tumor growth and cisplatin (DDP) resistance of TNBC [9]. As far as we know, chemotherapy is the standard therapeutic strategy for TNBC, and DDP is the most widely used chemotherapeutic drug for solid tumors. inconsistent chineseWebJun 16, 2008 · Cisplatin powder (Pharmachemie) was dissolved in 250 mL of a sterile, hypertonic solution containing 3% (w/v) NaCl and was administered as a 3-h continuous i.v. infusion at doses ranging from 50 to 100 mg/m 2 with treatment cycles repeated every week or every 3 weeks. Cisplatin was administered either alone or in combination with oral … inconsistent data types for the join keys kqlWebIt is reported that cisplatin is unstable in water, and insoluble in MeOH. Thought cisplatin can dissolve in DMSO and DMF, it can react with DMSO and DMF, forming adducts. inconsistent dist infoWebJul 12, 2024 · Cisplatin is a potent platinum-based anti-neoplastic agent that is believed to form inter- and intrastrand DNA adducts which activate signaling pathways culminating in … inconsistent class 10WebOct 22, 2024 · Cisplatin, powder or solution per 10 mg IV J9060 Cladribine per mg IV J9065 Claforan, see Cefotaxime sodium Clofarabine 1 mg IV J9027 . 2024 Table of Drugs 2024 Table of Drugs ... inconsistent compute_sudo for computed fieldsWebSep 27, 2024 · Cisplatin for injection has been administered at 50 mg/m 2 to 70 mg/m 2 intravenously per cycle once every 3 to 4 weeks. For heavily pretreated patients, an … inconsistent datatype error in oracle